HSDT
Helius Medical Technologies Inc.
$6.87
-$0.89(-11.47%)
48
Overall
60
Value
50
Tech
36
Quality
Market Cap
$25.99M
Volume
4.60M
52W Range
$5.37 - $1,200.00
Target Price
$4.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Mar | 2016 Mar | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | -- | $478.0K | $1.5M | $661.0K | $493.0K | $778.0K | $605.0K | $476.0K | ||
| Total Revenue | -- | -- | -- | $478.0K | $1.5M | $661.0K | $522.0K | $787.0K | $644.0K | $520.0K | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $1.4M | -- | -- | -- | $-846.0K | $388.0K | $298.0K | $463.0K | $583.0K | $582.0K | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $-1.4M | -- | -- | $478.0K | $650.0K | $273.0K | $224.0K | $324.0K | $61.0K | $-62.0K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $9.8M | $9.3M | $-22.9M | $-27.2M | $-24.6M | $14.7M | $18.4M | $15.1M | $12.5M | $13.8M | ||
| Research & Development | $4.5M | $3.6M | $14.4M | $9.9M | $8.1M | $4.6M | $6.0M | $4.3M | $2.9M | $3.7M | ||
| Research Expense | $4.5M | $3.6M | $14.4M | $9.9M | $8.1M | $4.6M | $6.0M | $4.3M | $2.9M | $3.7M | ||
| Selling, General & Administrative | $5.3M | $5.7M | $8.5M | $17.2M | $16.5M | $9.7M | $12.2M | $10.6M | $9.3M | $10.1M | ||
| Selling & Marketing Expenses | $774.4K | -- | -- | $17.2M | $16.5M | -- | -- | -- | $670.0K | $651.0K | ||
| General & Administrative Expenses | $5.3M | $5.7M | $8.5M | $17.2M | -- | $9.7M | $12.2M | $10.6M | $9.3M | $10.1M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | -- | -- | $670.0K | $651.0K | ||
| Salaries & Wages | $1.2M | -- | $-1.8M | $-8.1M | $-4.7M | -- | -- | -- | $1.6M | $2.5M | ||
| Depreciation & Amortization | -- | -- | -- | $-59.0K | $64.0K | $363.0K | $200.0K | $181.0K | $117.0K | $24.0K | ||
| Depreciation & Amortization | -- | -- | -- | $-59.0K | $64.0K | $363.0K | $200.0K | $181.0K | $117.0K | $24.0K | ||
| Amortization | -- | -- | -- | -- | $64.0K | $363.0K | $200.0K | $181.0K | $117.0K | $24.0K | ||
| Other Operating Expenses | $272.3K | -- | -- | -- | $-224.0K | $107.0K | $63.0K | $56.0K | $54.0K | $41.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-9.8M | $-9.3M | $-22.9M | $-26.7M | $-24.0M | $-14.4M | $-18.1M | $-15.5M | $-12.4M | $-13.9M | ||
| EBITDA | $-9.7M | $-6.8M | $-28.0M | $-28.6M | $-9.6M | $-13.9M | $-17.8M | $-14.5M | $-8.8M | $-11.7M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $176.5K | $46.9K | -- | -- | -- | -- | -- | $834.0K | -- | -- | ||
| Intinc | $20.1K | $150.3K | $-1.7M | $1.6M | $7.0K | -- | -- | $-834.0K | $257.0K | $-17.0K | ||
| Net Non-Operating Interest Income/Expense | $-156.4K | $103.3K | $-1.7M | $1.6M | $7.0K | -- | -- | $-834.0K | $257.0K | $-17.0K | ||
| Gain on Sale of Securities | $-739.4K | -- | $-3.4M | -- | $14.1M | $4.0K | -- | $3.0M | $3.0M | $3.0M | ||
| Other Income/Expense | $739.4K | $-268.3K | $3.4M | $3.5M | $-14.2M | $-256.0K | $-39.0K | $1.5M | $-2.9M | $-3.2M | ||
| Other Special Charges | $176.5K | $268.3K | $2.3M | $63.0K | $95.0K | $252.0K | $39.0K | $-740.0K | $119.0K | $247.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | $-1.5M | -- | -- | -- | -- | $-184.0K | -- | $-757.0K | $-159.0K | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $184.0K | -- | $757.0K | $159.0K | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-9.7M | $-6.8M | $-28.0M | $-28.6M | $-9.8M | $-14.4M | $-18.1M | $-14.8M | $-8.8M | $-11.7M | ||
| Pre-Tax Income | $-9.8M | $-6.9M | $-28.0M | $-28.6M | $-9.8M | $-14.1M | $-18.1M | $-14.1M | $-8.8M | $-11.7M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | $-5.9M | -- | -- | -- | $-4.0K | -- | -- | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-9.8M | $-6.9M | $-28.0M | $-28.6M | $-9.8M | $-14.1M | $-18.1M | $-14.1M | $-8.8M | $-11.7M | ||
| Net Income (Continuing Operations) | $-9.8M | $-6.9M | $-28.0M | $-28.6M | $-9.8M | $-14.1M | $-18.1M | $-14.1M | $-8.8M | $-11.7M | ||
| Net Income (Discontinued Operations) | $-9.8M | $-6.9M | $-28.0M | $-28.6M | $-9.8M | $-14.1M | $-18.1M | $-14.1M | $-8.8M | $-11.7M | ||
| Net Income (Common Stockholders) | $-9.8M | $-6.9M | $-28.0M | $-28.6M | $-9.8M | $-14.1M | $-18.1M | $-14.1M | $-8.8M | $-11.7M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-18.1M | -- | -- | $-11.6M | ||
| TOTALS | ||||||||||||
| Total Expenses | $9.8M | $9.3M | $-22.9M | $27.2M | $-25.5M | $15.0M | $18.7M | $15.5M | $13.1M | $14.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $8 | $66.5M | $14 | $17 | $20 | $31 | $65 | $359 | $810 | $2.7M | ||
| Average Shares Outstanding (Diluted) | $8 | $67.0M | $14 | $17 | $20 | $31 | $65 | $359 | $810 | $2.7M | ||
| Shares Outstanding | $11 | $84.3M | $15 | $19 | $24 | $61 | $101 | $752 | $1.2K | $6.1M | ||
| Basic EPS | -- | $-0.10 | -- | -- | $-485.6K | $-442.5K | $-276.8K | $-39.0K | $-10.9K | $-4.33 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-442.5K | $-276.8K | $-39.0K | $-10.9K | $-4.33 | ||
| Diluted EPS | $-1.1M | $-0.12 | $-2.0M | $-1.7M | $-485.6K | $-442.5K | $-276.8K | $-39.0K | $-10.9K | $-4.33 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-442.5K | $-276.8K | $-39.0K | $-10.9K | $-4.33 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D Income | -- | -- | $-3.4M | $-3.6M | -- | -- | -- | -- | -- | -- | ||
| Marketing Expense | $774.4K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | $1.5M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $5.3M | $5.7M | $8.5M | $17.2M | -- | $9.7M | $12.2M | $10.6M | $9.3M | $10.1M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | -- | -- | $159.0K | $40.0K | ||
| Rent And Landing Fees | $5.3M | $5.7M | $8.5M | $17.2M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | -- | $17.2M | $16.5M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HSDT | $6.87 | -11.5% | 4.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Helius Medical Technologies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW